✦ LIBER ✦

Angiographic and clinical comparison of novel Orsiro Hybrid sirolimus-eluting stents and Resolute Integrity zotarolimus-eluting stents in all-comers with coronary artery disease (ORIENT trial): study protocol for a randomized controlled trial

✍ Scribed by Lee, Joo Myung; Park, Sang-Don; Lim, Sang Yup; Doh, Joon-Hyung; Cho, Jin Man; Kim, Ki-Seok; Bae, Jang-Whan; Chung, Woo-Young; Youn, Tae-Jin

Book ID: 121598705
Publisher: BioMed Central
Year: 2013
Tongue: English
Weight: 263 KB
Volume: 14
Category: Article
ISSN: 1468-6708
DOI: 10.1186/1745-6215-14-398

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of Zotarolimus-Eluting and Si

Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients With Native Coronary Artery Disease: A Randomized Controlled Trial

✍ David E. Kandzari; Martin B. Leon; Jeffrey J. Popma; Peter J. Fitzgerald; Charle 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 472 KB

Comparison of Resolute Zotarolimus-Eluti

Comparison of Resolute Zotarolimus-Eluting Stent and Sirolimus-Eluting Stents in Patients with Long Coronary Artery Lesions: A Randomized LONGDES IV Trial

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 290 KB

AS-218 Comparison of Resolute zotarolimu

AS-218 Comparison of Resolute zotarolimus-eluting stent and Sirolimus-Eluting Stents in Patients with Long Coronary Artery Lesions: A Randomized LONG-DES IV Trial

✍ Jung-Min Ahn; Hae-Geun Song; Jong-Young Lee; Won-Jang Kim; Duk-Woo Park; Soo-Jin 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 303 KB

Comparison of the efficacy and safety of

Comparison of the efficacy and safety of paclitaxel-eluting coroflex please stents and paclitaxel-eluting stents in patients with coronary artery disease: A randomized PIPA trial

✍ Hyun-Sook Kim; Seung-Jung Park; Duk-Woo Park; Seong-Wook Park; Sang-Sig Cheong; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 901 KB

Late-Term Clinical Outcomes With Zotarol

Late-Term Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting Stents: 5-Year Follow-Up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)

✍ David E. Kandzari; Laura Mauri; Jeffrey J. Popma; Mark A. Turco; Paul A. Gurbel; 📂 Article 📅 2011 🏛 American College of Cardiology 🌐 English ⚖ 704 KB

TCT-565 NOYA I: A Prospective Randomized

TCT-565 NOYA I: A Prospective Randomized Trial of the Biodegradable Polymer NOYA Sirolimus-Eluting Stent Compared with the Durable Polymer FIREBIRD 2 Sirolimus-Eluting Stent in Patients with Coronary Artery Disease: 9-Month Angiographic and 24-Month Clinical Results

✍ Bo Xu; Kefei Dou; Yuejin Yang; Shuzheng Lu; Lefeng Wang; Haichang Wang; Zhanquan 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 80 KB